BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12880723)

  • 1. Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burns.
    Holder IA; Durkee P; Supp AP; Boyce ST
    Burns; 2003 Aug; 29(5):445-8. PubMed ID: 12880723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
    Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
    J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing.
    Yin HQ; Langford R; Burrell RE
    J Burn Care Rehabil; 1999; 20(3):195-200. PubMed ID: 10342470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the penetration of nanocrystalline silver through various wound dressing mediums: An in vitro study.
    Potgieter MD; Meidany P
    Burns; 2018 May; 44(3):596-602. PubMed ID: 29290512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
    Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
    J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study.
    Innes ME; Umraw N; Fish JS; Gomez M; Cartotto RC
    Burns; 2001 Sep; 27(6):621-7. PubMed ID: 11525858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Controlled Study of Silver-Based Burns Dressing in a Pediatric Emergency Department.
    Brown M; Dalziel SR; Herd E; Johnson K; Wong She R; Shepherd M
    J Burn Care Res; 2016; 37(4):e340-7. PubMed ID: 26171678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.
    Tredget EE; Shankowsky HA; Groeneveld A; Burrell R
    J Burn Care Rehabil; 1998; 19(6):531-7. PubMed ID: 9848045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial efficacy of a novel silver hydrogel dressing compared to two common silver burn wound dressings: Acticoat™ and PolyMem Silver(®).
    Boonkaew B; Kempf M; Kimble R; Supaphol P; Cuttle L
    Burns; 2014 Feb; 40(1):89-96. PubMed ID: 23790588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
    Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
    J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Acticoat dressings in burns: what is the evidence?
    Khundkar R; Malic C; Burge T
    Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of three silver dressings in an infected animal model.
    Heggers J; Goodheart RE; Washington J; McCoy L; Carino E; Dang T; Edgar P; Maness C; Chinkes D
    J Burn Care Rehabil; 2005; 26(1):53-6. PubMed ID: 15640735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antimicrobial spectrum of Xeroform
    Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
    Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
    Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
    Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of flow cytometry to compare the antimicrobial efficacy of silver-containing wound dressings against planktonic Staphylococcus aureus and Pseudomonas aeruginosa.
    Percival SL; Slone W; Linton S; Okel T; Corum L; Thomas JG
    Wound Repair Regen; 2011; 19(3):436-41. PubMed ID: 21518089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Acticoat with nanocrystalline silver in the management of burns.
    Dunn K; Edwards-Jones V
    Burns; 2004 Jul; 30 Suppl 1():S1-9. PubMed ID: 15327800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
    Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
    Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acticoat dressings and major burns: systemic silver absorption.
    Moiemen NS; Shale E; Drysdale KJ; Smith G; Wilson YT; Papini R
    Burns; 2011 Feb; 37(1):27-35. PubMed ID: 20961690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of silver-containing antimicrobial dressings and drugs.
    Castellano JJ; Shafii SM; Ko F; Donate G; Wright TE; Mannari RJ; Payne WG; Smith DJ; Robson MC
    Int Wound J; 2007 Jun; 4(2):114-22. PubMed ID: 17651227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.